The AJMC® clinical page includes all the published content across AJMC.com, The American Journal of Managed Care® and Evidence-Based Oncology™ on a variety of specialties, including dermatology, cardiology, oncology, and rheumatology.
September 27th 2024
An oral session Friday at the International Myeloma Society 21st Annual Meeting & Exposition offered updates for the TRIMM-2 and RedirecTT-1 trials.
September 27th 2024
City of Hope: Adapting Pharmacy Roles With an Eye Toward Retention
October 15th 2022Leaders from City of Hope National Medical Center discussed how the cancer research and treatment center addressed challenges with attracting and retaining oncology pharmacists through a restructuring during the ACCC 39th National Oncology Conference.
Read More
Hydroxychloroquine for Primary Sjögren Syndrome Does Not Lower Risk of SLE
October 12th 2022However, the researchers said their findings should not be interpreted as completely refuting the possibility that hydroxychloroquine might be a useful tool in preventing or slowing the development of systemic lupus erythematosus (SLE).
Read More
Patients With Lower-Risk MF, Low- or High-Risk ET Report Significant QOL Impacts
October 12th 2022Despite the use of therapies to address the clinical manifestations of myelofibrosis (MF) and essential thrombocythemia (ET), the symptom burdens of these conditions continue to negatively affect patient quality of life (QOL).
Read More
Review Finds Insufficient Evidence Supporting Corticosteroid Irrigation for CRS With Nasal Polyps
October 12th 2022A search of the peer-reviewed literature turned up inconsistent findings on the effectiveness of corticosteroid irrigation for the treatment of chronic rhinosinusitis (CRS) with nasal polyps.
Read More
ICER to Assess Clinical Effectiveness, Value of 2 NASH Treatments
October 11th 2022There are no FDA-approved therapies for nonalcoholic steatohepatitis (NASH), but there are many being developed. Resmetirom and obeticholic acid are both being reviewed by the FDA with decisions expected in 2023.
Read More
Researchers Explore Similarities, Differences in Guidelines for PsA Treatment
October 11th 2022In the last 2 years, the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) and the European Alliance of Associations for Rheumatology (EULAR) have updated their recommendations to integrate guidance for new treatment options.
Read More
For COPD Treated in Primary Care, ICS May Be Inappropriately Prescribed
October 8th 2022Inhaled corticosteroid (ICS) therapy was not the most appropriate treatment for many patients with chronic obstructive pulmonary disease (COPD) in a review of patient records at 2 US primary care clinics.
Read More
Study of IL-17A Treatment Underscores Potential of circRNA as Biomarker in Psoriasis
October 8th 2022The study, which assessed changes in circRNA and miRNA after beginning treatment with secukinumab, revealed a prompt change in circRNA abundance upon initiation of treatment and a strong correlation between circRNA and the psoriasis area and severity index.
Read More
New eGFR Formula May Inappropriately Label Black Potential Kidney Donors as Having CKD
October 7th 2022This study found that the recent change to remove race from the calculation of estimated glomerular filtration rate (eGFR) may incorrectly label potential donors who are Black as having chronic kidney disease (CKD).
Read More